Literature DB >> 29761738

eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.

Rosalba Rosato1, Silvia Testa1, Antonio Bertolotto2, Francesco Scavelli2, Ambra M Giovannetti3, Paolo Confalonieri4, Francesco Patti5, Clara Grazia Chisari5, Alessandra Lugaresi6, Erika Pietrolongo6, Maria Grazia Grasso7, Ilaria Rossi7, Anna Toscano1, Barbara Loera1, Andrea Giordano8, Alessandra Solari9.   

Abstract

BACKGROUND: We recently devised a shortened version of the 54-item Multiple Sclerosis Quality of Life (MSQOL-54) in paper (MSQOL-29, consisting of 25 items forming 7 subscales and 4 single items, and one filter question for 3 'sexual function' items) and electronic format (eMSQOL-29).
OBJECTIVES: To prospectively assess eMSQOL-29 psychometric properties, acceptability/equivalence versus MSQOL-29.
METHODS: Multiple sclerosis (MS) patients ( n = 623; Expanded Disability Status Scale (EDSS) range 0.0-9.0) completed eMSQOL-29, Hospital Anxiety and Depression Scale, Functional Assessment of MS (FAMS), European Quality of life Five Dimensions-3L, and received EDSS and Symbol Digit Modalities Test (SDMT). Equivalence versus MSQOL-29 was assessed in 242 patients (randomized cross-over design).
RESULTS: 'Sexual function' items were filtered out by 273 patients (47%). No multi-item scale had floor effect, while five had ceiling effect. Cronbach's alpha range was 0.88-0.90. Confirmatory factor analysis showed good overall fit and the two-factor solution for composite scores was confirmed. Criterion validity was sub-optimal for 'cognitive function' (vs SDMT, r = 0.25) and 'social function' (vs FAMS social function, r = 0.38). eMSQOL-29 equivalence was confirmed and its acceptability was good.
CONCLUSION: eMSQOL-29 showed good internal consistency, factor structure and no floor effect, while most subscales had some ceiling effect. Criterion validity was sub-optimal for two subscales. Equivalence and acceptability were good.

Entities:  

Keywords:  Health-related quality of life; MSQOL-54; electronic migration; multiple sclerosis; patient reported outcomes; psychometric assessment

Mesh:

Year:  2018        PMID: 29761738     DOI: 10.1177/1352458518774935

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  3 in total

1.  Assessing measurement invariance of MSQOL-54 across Italian and English versions.

Authors:  Andrea Giordano; Silvia Testa; Marta Bassi; Sabina Cilia; Antonio Bertolotto; Maria Esmeralda Quartuccio; Erika Pietrolongo; Monica Falautano; Monica Grobberio; Claudia Niccolai; Beatrice Allegri; Rosa Gemma Viterbo; Paolo Confalonieri; Ambra Mara Giovannetti; Eleonora Cocco; Maria Grazia Grasso; Alessandra Lugaresi; Elisa Ferriani; Ugo Nocentini; Mauro Zaffaroni; Alysha De Livera; George Jelinek; Alessandra Solari; Rosalba Rosato
Journal:  Qual Life Res       Date:  2019-11-09       Impact factor: 4.147

2.  Perception of COVID-19 Pandemic by Brazilian People With Parkinson's Disease and Multiple Sclerosis.

Authors:  Lucas Simieli; Felipe B Santinelli; Elisa C Costa; Marina H Kuroda; Lorena R Oliveira; Tiago Penedo; Julia Pilon; Aline P B Silveira; Iramaia S A Assis; Erica Tardelli; Erika Okamoto; Fabio A Barbieri
Journal:  Front Psychol       Date:  2022-05-19

3.  Study protocol on advance care planning in multiple sclerosis (ConCure-SM): intervention construction and multicentre feasibility trial.

Authors:  Ludovica De Panfilis; Simone Veronese; Michela Bruzzone; Marta Cascioli; Alberto Gajofatto; Maria Grazia Grasso; Paola Kruger; Alessandra Lugaresi; Leigh Manson; Sara Montepietra; Francesco Patti; Eugenio Pucci; Claudio Solaro; Andrea Giordano; Alessandra Solari
Journal:  BMJ Open       Date:  2021-08-13       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.